Table 3.
Treatment characteristics.
| Patient | Previous RT (EBRT and HDR) |
CTV volume (mm3) |
SBRT dose/Fx |
SBRT dose equivalent (2 Gy/fx) alpha/beta 10 |
SBRT dose equivalent (2 Gy/fx) alpha beta 3 |
|---|---|---|---|---|---|
| 1 | 45 + 30 Gy HDR | 254485.7 | 27.5/5 | 35.52083 | 46.75 |
| 2 | 45 | 9893.03 | 25/5 | 31.25 | 40 |
| 3 | 50.4 | 34818.04 | 25/5 | 31.25 | 40 |
| 4 | 45 | 19947.13 | 25/5 | 31.25 | 40 |
| 5 | 45 | 40721.84 | 22.5/5 | 27.1875 | 33.75 |
| 6 | 45 | 129132.1 | 5/1 | 6.25 | 8 |
| 7 | 45 | 174427.2 | 25/5 | 31.25 | 40 |
| 8 | 45 | 11549.91 | 24/5 | 29.6 | 37.44 |
| 9 | 45 + 12 HDR | 16655.7 | 15/3 | 18.75 | 24 |
| 10 | 45+ 30 HDR | 143710.1 | 25/5 | 31.25 | 40 |
| 11 | 45 | 45809.38 | 25/5 | 31.25 | 40 |